Jiangsu Macro micro-test Medical Technology

Macro & Micro Test, founded in 2010 in Beijing, a company being committed to the research, development and production of new detection technologies and novel in vitro diagnostic reagents based on its self-developed patent technologies. With its continuous endeavors and achievements, the company has established three industrial bases in Beijing, Nantong and Suzhou with GMP workshops and R&D laboratories around 16,000 m2 in total. The company has successively undertaken quite a few significant projects such as the National Infectious Disease Project, the National High-Tech R&D Program (Program 863), the National Key Basic R&D Program (Program 973) and the National Natural Science Foundation of China. Moreover, close collaboration has been established with top scientific institutions in China, and over 20 national patents has been obtained. Up to now, more than 200 diagnostic products have been developed covering infectious disease prevention and control, reproductive health testing, genetic disease testing, personalized drug gene testing, COVID-19 detection and other business fields.

Macro & Micro Test has molecular diagnosis, immunization, POCT and other technology platforms with professional R&D, production, management and operation teams, "high-tech enterprise" certified by Jiangsu Province. It has passed TUV EN ISO13485:2016, CMD YY/T 0287-2017 IDT IS 13485:2016, GB/T 19001-2016 IDT ISO 9001:2015 and some products CE certification.